SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (12442)8/1/1998 4:53:00 PM
From: AlienTech  Read Replies (1) | Respond to of 23519
 
Lets put it this way, I'll be holding my breath to see under 5.



To: VLAD who wrote (12442)8/2/1998 11:47:00 PM
From: Mark A. Stang  Read Replies (1) | Respond to of 23519
 
>>Vivus already has some sort of verbal deal with AZA for a stock swap. On a share to share basis, Vivus will get about 17 to 18 per share. <<

As Yogi Berra would say, that verbal deal would not be worth the paper it's written on. What consideration do you suppose Vivus would have given AZA for a $17-$18 December put?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News